I think that people often forget about chronically ill teenagers. We aren't adults yet, but we also aren’t little kids anymore. We're in the middle of everything and everyone. We can understand...
Please share your success stories for ASPIRE’s 2021 Triumphs Highlights! We all know PANS PANDAS is rough (understatement) but let’s take a moment to celebrate the successes from the past...
J Huang, R Li, L Li, Y Song, L Jin. The relationship between allergic diseases and tic disorders: A systematic review and meta-analysis. Neuroscience & Biobehavioral Reviews, Vol 132, 2022, DOI: 10.1016/j.neubiorev.2021.12.004.
Success! Ben’s cookie fundraiser was incredibly successful! Ben and his family combined a fundraiser with an awareness event. They took cookie preorders and sold cookies and beverages near...
This trifold brochure briefly explains PANS PANDAS, families' next steps, where to get more help and ASPIRE...
Is It Mental Health or Medical? PANDAS/PANS (Pediatric Autoimmune Neuropsychiatric Disorders Associated with Streptococcal Infection/Pediatric Acute-onset Neuropsychiatric Syndrome) The Family Court...
CDC’s Autism Numbers The CDC has released the new estimated Autism Prevalence rates. They report that 1 in 44 or 2.27% of American 8-year-olds have an autism spectrum disorder (ASD)...
Breaking Free of Child Anxiety and OCD: A Scientifically Proven Program for Parents is the first and only book to provide a completely parent-based treatment program for child and adolescent...
V Nezgovorova, CJ Ferretti, S Pallanti, E Hollander. Modulating neuroinflammation in COVID-19 patients with obsessive-compulsive disorder. Journal of Psychiatric Research, 2021, DOI: 10.1016/j.jpsychires.2021.11.025.
Abstract: Exacerbation of symptoms of obsessive-compulsive disorder (OCD) during COVID-19 or new onset of the OCD symptoms resulting from COVID-19 infection is an understudied area of research. It is possible that increased proinflammatory immune status is associated with the onset of obsessive-compulsive symptoms in patients with COVID-19 and that targeted anti-inflammatory treatments for COVID-19 infection can mitigate the new onset of Obsessive-Compulsive (OC) spectrum symptoms. In this review, we cover OCD pathogenesis as related to COVID-19, summarize the impact of cytokines on behavior, and suggest that anti-cytokine treatments can help mitigate post-COVID-19 and new onset of the OC symptoms.
"Timely treatment with IV immunoglobulin (IVIG) therapy can help children who develop obsessive-compulsive disorder (OCD) and other severe psychiatric or neurologic symptoms in the aftermath of...
Our family and B have gone through so much since December 2018. It has been completely devastating emotionally, mentally, physically, and financially. At the time, there didn’t seem to be...
